Robert Haney Discusses Biotech- AI Convergence and Trade Secret Risks with IAM
Partner Robert (Bob) Haney, Jr. was recently featured in IAM discussing the growing convergence of biotech innovation and artificial intelligence .
Read the original at Foley Hoag LLP ↗
- Tracked via
- “AI Risks”